(Q38329856)

2 September 2017

title

Targeting RNase L to human immunodeficiency virus RNA with 2-5A-antisense (English)

1 reference

2 September 2017

M R Player

1

1 reference

2 September 2017

R K Maitra

series ordinal

2

1 reference

2 September 2017

R H Silverman

series ordinal

3

1 reference

2 September 2017

P F Torrence

series ordinal

4

1 reference

2 September 2017

publication date

1 May 1998

1 reference

Antiviral Chemistry & Chemotherapy

2 September 2017

published in

1 reference

2 September 2017

volume

9

1 reference

2 September 2017

issue

3

1 reference

2 September 2017

page(s)

225-231

1 reference

Comparative hybrid arrest by tandem antisense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylphosphonates in a cell-free system

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Incorporation of the catalytic domain of a hammerhead ribozyme into antisense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Phosphorothioate analogues of oligodeoxyribonucleotide: synthesis and activity as inhibitors of replication of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

A comparison of gag, pol and rev antisense oligodeoxynucleotides as inhibitors of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Specific inhibition of human immunodeficiency virus type 1 replication by antisense oligonucleotides: an in vitro model for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Catalytic cleavage of an RNA target by 2-5A antisense and RNase L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Oligodeoxynucleotide analogs with 5'-linked anthraquinone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Current concepts in antisense drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Specific inhibition of human immunodeficiency virus type 1 replication by RNA transcribed in sense and antisense orientation from the 5'-leader/gag region

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Inhibition of human immunodeficiency virus (HIV-1) replication by synthetic oligo-RNA derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Targeting RNA for degradation with a (2'-5')oligoadenylate-antisense chimera

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Recruiting the 2-5A system for antisense therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Pharmacokinetics of an anti—human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects*

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Computer prediction of RNA structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900303

10.1177/095632029800900303

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference